A Cross-Trial Comparison of Pegcetacoplan and Avacincaptad Pegol by Paul Hahn, M.D.

Published Date: 10 Aug 2023

In patients with geographic atrophy, Dr. Dot Hahn discusses an indirect comparison that is anchored matching-adjusted and suggests that monthly pegcetacoplan is more effective than avacincaptad pegol at reducing observed lesion growth.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot